Palamedrix is a DNA nanotechnology based company building a disruptive tool for life sciences and medicine. By utilizing biosensors engineered to capture small molecules present in biological samples, we can pinpoint the presence of any analyte with single-molecule accuracy. Further, organizing the molecular sensors using proprietary CMOS technologies, the Palamedrix platform is capable of delivering comprehensive data for doctors and patients to get a highly-accurate, complete view of an individual’s biochemistry with a single test. This comprehensive dataset enables biochemical insights for informed diagnoses and therapeutic interventions, forging a new era of data-driven healthcare.